Muscimol Gummies: Effects, Safety, and What to Know Before You Buy
Muscimol is one of the most searched psychoactive compounds in the US right now — and one of the most widely misunderstood. This guide covers what muscimol actually does at the receptor level, what the dose-response curve looks like, what the safety profile is, and what the FDA's December 2024 action means for products on the market today.
Looking for a legal, lab-tested botanical gummy? See Wunder's lineup →
What Is Muscimol?
Muscimol is the primary psychoactive compound in Amanita muscaria — the red-and-white mushroom that shows up in folklore, art, and video games. Unlike psilocybin, which targets serotonin receptors (5-HT2A), muscimol is a GABA-A receptor agonist. That puts it in the same receptor family as alcohol, benzodiazepines, and kava.
That receptor difference means a completely different experience. Muscimol is sedating and dissociative, not classically psychedelic. Users report body warmth, dreamlike or hypnagogic states, deep introspection, and at higher doses, significant disorientation. There are no psilocybin-style visual hallucinations.
On the legal side: muscimol is not a DEA-scheduled substance. It is federally legal in most of the US. That is why it is sold openly online.
One critical processing note: Raw Amanita muscaria contains ibotenic acid, which converts to muscimol through heat and decarboxylation. Poorly processed products can have dangerously high residual ibotenic acid, which causes nausea, vomiting, and other unpleasant effects. A legitimate muscimol product uses standardized extract — not raw mushroom powder.
How Muscimol Works: Receptor-Level Breakdown
Muscimol binds to GABA-A receptors in the brain. GABA (gamma-aminobutyric acid) is the brain's primary inhibitory neurotransmitter — it slows neural activity, reduces anxiety, and promotes sedation.
This is fundamentally different from how classic psychedelics work. Here is the comparison at the receptor level:
| Compound | Primary Receptor Target | Receptor Type | Effect Category |
|---|---|---|---|
| Muscimol | GABA-A | Inhibitory | Sedative, dissociative, hypnotic |
| Psilocybin / Psilocin | 5-HT2A (serotonin) | Excitatory (modulatory) | Psychedelic, perceptual, entheogenic |
| THC (cannabis) | CB1 (endocannabinoid) | Modulatory | Euphoric, relaxing, appetite-stimulating |
| CBD (cannabis) | Multiple (5-HT1A, TRPV1, etc.) | Modulatory | Anxiolytic, anti-inflammatory, non-psychoactive |
| Kava (kavalactones) | GABA-A (distinct binding site) | Inhibitory | Anxiolytic, muscle-relaxing, mildly euphoric |
Muscimol and kava share the GABA-A receptor family but bind to different sites on the receptor complex. That means they both produce relaxation and sedation, but through slightly different mechanisms — and kava has a much longer documented history of safe human use.
Muscimol Effects Timeline and Dosage Guide
Onset and Duration
| Phase | Timing | What to Expect |
|---|---|---|
| Onset | 30–90 minutes after ingestion | Gradual warmth, muscle relaxation, slight heaviness in limbs. Onset is slower with food in stomach. |
| Peak | 2–4 hours | Deep sedation, dreamlike mental state, introspection, potential disorientation at higher doses. |
| Plateau | 1–3 hours | Sustained sedative effects. Users often report feeling "heavy" or "anchored." |
| Comedown | 1–2 hours | Gradual return to baseline. Residual drowsiness common. No hangover reported at low-moderate doses. |
| Total Duration | 4–8 hours | Highly variable based on dose, metabolism, and body weight. |
Dose Reference Table
Warning: The muscimol dose-response curve is steep. The gap between a pleasant, sedating experience and an overwhelming, confusing one is narrower than with psilocybin or cannabis. Start low.
| Dose Range | Category | Effects | Duration |
|---|---|---|---|
| 1–3 mg | Threshold / Microdose | Subtle relaxation, mild mood lift. No sedation or impairment. Functional. | 3–5 hours |
| 3–7 mg | Low / Moderate | Noticeable sedation, body warmth, mild dissociation, introspection. Not recommended for activities requiring coordination. | 4–7 hours |
| 7–12 mg | High | Strong sedation, significant disorientation, dreamlike/hypnagogic states, potential nausea. Do not operate vehicles or machinery. Have a sitter. | 5–8 hours |
| 12+ mg | Very High / Dangerous | Severe disorientation, loss of motor control, vomiting, risk of respiratory depression when combined with other CNS depressants. Do not attempt without medical supervision. | 8+ hours |
These dose ranges assume a standardized muscimol extract with known potency. Products that do not list milligram counts per serving are impossible to dose accurately. Do not guess.
Safety Profile and Contraindications
Known Risks
- Steep dose-response curve. The difference between 5 mg and 10 mg is not "twice as strong" — it can be the difference between a pleasant evening and a disorienting, frightening experience.
- Ibotenic acid contamination. Improperly processed products contain residual ibotenic acid, a neurotoxin that causes nausea, vomiting, and at high doses, neurotoxic effects. Published research (Michelot & Melendez-Howell, 2003, Mycological Research) documents ibotenic acid's mechanism as a glutamate agonist that can cause excitotoxic damage.
- CNS depressant interactions. Muscimol potentiates other central nervous system depressants including alcohol, benzodiazepines, opioids, and sedating antihistamines. Combining muscimol with any of these increases the risk of respiratory depression, loss of consciousness, and overdose.
- Delirium at high doses. Above ~10 mg, users may experience confusion, agitation, and what clinicians describe as a delirium-like state. This is distinct from psychedelic experiences — the user may be unable to distinguish reality from dream states.
Medical Contraindications
Muscimol use should be avoided or approached with extreme caution if you:
- Take benzodiazepines, barbiturates, or sleep medications (additive CNS depression)
- Take prescription GABAergic medications (gabapentin, pregabalin, baclofen)
- Have liver or kidney impairment (muscimol metabolism and elimination pathways are not fully characterized in humans)
- Are pregnant or breastfeeding (zero safety data in pregnancy — do not use)
- Have a history of seizures or epilepsy (GABA-A agonism can paradoxically lower seizure threshold in some individuals)
- Have a personal or family history of psychosis or schizophrenia
What the Research Says
Human research on muscimol is extremely limited. Most available data comes from animal studies, case reports, and ethnobotanical accounts of traditional Amanita muscaria use in Siberian and Nordic cultures.
Key references:
- Michelot, D. & Melendez-Howell, L.M. (2003). "Amanita muscaria: chemistry, biology, toxicology, and ethnomycology." Mycological Research, 107(2), 131–146. — Comprehensive review of chemistry and toxicology.
- Johnston, G.A.R. (2014). "Muscimol as an ionotropic GABA receptor agonist." Neurochemical Research, 39(10), 1942–1947. — Receptor pharmacology.
- FDA Alert (December 2024). "FDA Warns Against Consuming Products Containing Amanita Muscaria Mushrooms." — Regulatory status and consumer illness reports.
What the FDA Said in December 2024
In December 2024, the FDA formally declared Amanita muscaria and its constituents — muscimol, ibotenic acid, and muscarine — to be unapproved food additives, not GRAS (Generally Recognized as Safe). The agency also linked amanita supplement products to consumer illness reports.
This action did not schedule muscimol as a controlled substance. Possession and consumption remain legal at the federal level. But the FDA's position carries weight — payment processors, platforms, and insurers treat FDA warnings as risk signals. Several brands reformulated or pulled their amanita lines after the alert.
This is part of why Wunder chose a different path. Our products do not contain amanita muscaria or muscimol.
Muscimol vs. Psilocybin vs. THC vs. CBD: Full Comparison
| Muscimol | Psilocybin | THC | CBD | |
|---|---|---|---|---|
| Source | Amanita muscaria mushroom | Psilocybe mushrooms | Cannabis sativa/indica | Cannabis sativa/indica (hemp) |
| Primary Receptor | GABA-A | 5-HT2A (serotonin) | CB1 (endocannabinoid) | Multiple (5-HT1A, TRPV1, etc.) |
| Federal Legal Status | Legal (not scheduled) | Schedule I — illegal | Schedule I (hemp-derived Δ9 ≤0.3% is federally legal per 2018 Farm Bill) | Legal (hemp-derived) |
| FDA Position | Unapproved food additive (Dec 2024) | No food/supplement path | No food/supplement path (except Epidiolex) | Approved drug (Epidiolex); not approved as supplement |
| Effect Character | Sedating, dissociative, dreamlike | Perceptual, entheogenic, emotional | Euphoric, relaxing, appetite-stimulating | Anxiolytic, anti-inflammatory, non-intoxicating |
| Onset (oral) | 30–90 min | 30–60 min | 30–90 min | 30–60 min |
| Duration | 4–8 hours | 4–6 hours | 2–6 hours | 4–6 hours |
| Dose Sensitivity | High — steep curve, narrow safety margin | Moderate | Low to moderate | Very low — wide safety margin |
| Overdose Risk | Moderate (CNS depression, especially with other sedatives) | Low (physiologically; psychological distress risk is real) | Very low (physiologically) | Negligible |
| Addiction Potential | Unknown (insufficient human data) | Low | Moderate (~9% of users develop CUD) | None established |
| Drug Testing | Not on standard panels | Not on standard panels (specialized test required) | Yes — standard THC metabolite panel | Not on standard panels |
What to Look for in a Muscimol Product
If you are going to buy muscimol gummies, verify these three things before you pay:
- Muscimol milligrams per serving stated clearly on the label. "Amanita extract 500mg" is worthless — that could be 0.5 mg of muscimol or 50 mg. You need to know the active compound dose.
- Third-party COA showing muscimol content and low ibotenic acid. The COA should confirm potency and screen for residual ibotenic acid. If the brand does not publish COAs or makes you email to request them, skip it.
- Standardized extract — not raw mushroom powder. Raw Amanita muscaria powder has unpredictable muscimol:ibotenic acid ratios. Standardized extraction with decarboxylation processing is the minimum bar for safety.
Red flags:
- No muscimol mg listed on the label
- No COA available anywhere on the site
- "Amanita extract" or "proprietary mushroom blend" with no standardization data
- Synthetic muscimol without disclosure
- Products that claim to contain both psilocybin AND muscimol (selling a Schedule I drug openly is not a sign of a quality operation)
What Wunder Does Instead
We evaluated amanita muscaria carefully. The ibotenic acid processing variability, the FDA's December 2024 position, and the narrow safety margin pushed us toward a different formulation.
Wunder's lineup uses a proprietary high-potency mushroom blend — not psilocybin, not amanita muscaria. We add botanicals that we believe have a stronger safety and regulatory profile: kava, blue lotus, and kanna.
If you are specifically interested in muscimol's GABA-A mechanism, kava is worth knowing about. Kava's active compounds (kavalactones) also target GABA-A receptors — same receptor family as muscimol, different compound, different sourcing, legal everywhere, and with centuries of documented safe human use in Pacific Island cultures.
Every Wunder product ships with a third-party COA. Clear labeling by compound and milligram count. No "proprietary blend" black boxes.
FAQ
What are muscimol gummies?
Gummies made from standardized Amanita muscaria extract. The active compound is muscimol, a GABA-A receptor agonist that produces sedating and dissociative effects. These are distinct from psilocybin's serotonergic, psychedelic effects — different receptor, different experience.
Is muscimol legal in the US?
Yes, at the federal level. Muscimol is not a DEA-scheduled substance. The FDA issued an alert in December 2024 classifying amanita muscaria as an unapproved food additive, but that is a regulatory status, not a criminal one. A small number of states (Louisiana, Arkansas) have added their own restrictions. Check your state's status →
Are muscimol gummies safe?
Standardized muscimol extract has a real-world safety record among experienced users who dose carefully. The primary risks are: (1) ibotenic acid contamination from poorly processed product, and (2) dose sensitivity — the curve between a comfortable dose and an overwhelming one is steeper than with psilocybin or cannabis. Start low, verify the COA, and never combine with alcohol or other CNS depressants.
What did the FDA say about muscimol gummies?
In December 2024, the FDA warned consumers against products containing Amanita muscaria, declaring muscimol, ibotenic acid, and muscarine to be unapproved food additives and citing consumer illness reports. Read the full FDA alert here.
What is the difference between muscimol and psilocybin?
Completely different mechanisms and effects. Muscimol hits GABA-A receptors — sedating, dissociative, dreamy. Psilocybin hits 5-HT2A serotonin receptors — perceptual, entheogenic, classic psychedelic. Muscimol is federally legal; psilocybin is Schedule I.
What is a safe muscimol dose?
A threshold dose is 1–3 mg. A moderate dose is 3–7 mg. Above 7 mg, disorientation becomes significant. Above 12 mg, the experience can be dangerous, especially if combined with other CNS depressants. Always verify your product's stated milligram count with a COA before dosing.
Does Wunder sell muscimol gummies?
No. Wunder does not carry amanita muscaria or muscimol products. Our formulations use a different entheogenic mushroom blend plus kava, blue lotus, and kanna.
What is the closest thing Wunder sells to muscimol gummies?
Our kava-blend gummies. Kava's kavalactones target GABA-A receptors — the same receptor family muscimol hits. The experience is different, but the receptor mechanism is the closest analog in our lineup. See the Kava + Grape Gummy →
How do muscimol gummies make you feel?
At low-moderate doses (3–7 mg): relaxed, warm, mildly sedated, with a dreamlike mental quality. At higher doses (7+ mg): significant disorientation, dissociation, and what some describe as hypnagogic hallucinations. Not like psilocybin. The dose-response curve is steep — small increases in dose produce large changes in effect intensity.
Can muscimol show up on a drug test?
Muscimol is not included on standard workplace drug panels (SAMHSA-5, 10-panel, or expanded panels). It is chemically unrelated to THC, opioids, amphetamines, benzodiazepines, cocaine, or PCP. Specialized testing would be required to detect it, and such testing is extremely rare outside of research or forensic contexts.
Want to go deeper on the mushroom? Read our full Amanita Muscaria Gummies guide →
Wondering what is legal in your state? See our Legal Mushroom Gummies state-by-state guide →
Last updated: July 13, 2026. The information on this page is educational and does not constitute medical or legal advice. Muscimol dose ranges are based on user reports and available literature, not clinical trials. Individual responses vary. Always consult a healthcare provider before using any psychoactive substance.
